ATS 2023 Insights


 

ATS 2023 Insights: Effect of Ensifentrine, a Novel PDE3 and PDE4 Inhibitor, on Lung Function, Symptoms and Exacerbations in Patients With COPD: The ENHANCE Trials

1,175 views
June 14, 2023
Comments 0
Login to view comments. Click here to Login